CYP2D6, serotonin and suicide

被引:0
|
作者
Ahlner, Johan [1 ]
Zackrisson, Anna-Lena [1 ]
Lindblom, Bertil [1 ]
Bertilsson, Leif [2 ]
机构
[1] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, SE-58758 Linkoping, Sweden
[2] Karolinska Inst, Div Clin Pharmacol, Kaolinska Univ Hosp, Linkoping, Sweden
关键词
ANTIDEPRESSANTS; PERSONALITY; DISORDERS; PHENOTYPE;
D O I
10.2217/PGS.10.84
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:903 / 905
页数:3
相关论文
共 50 条
  • [1] CYP2D6, serotonin, and suicide-a relationship?
    Bertilsson, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 304 - 305
  • [2] CYP2D6 and Hormones: Implications for Suicide
    Lopez-Castroman, Jorge
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 153S - 153S
  • [3] CYP2D6 and Personality: Implications for Suicide
    Blasco-Fontecilla, Hilario
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 62S - 62S
  • [4] CYP2D6 and the severity of suicide attempts
    Penas-Lledo, Eva M.
    Blasco-Fontecilla, Hilario
    Dorado, Pedro
    Vaquero-Lorenzo, Concepcion
    Baca-Garcia, Enrique
    Llerena, Adrian
    [J]. PHARMACOGENOMICS, 2012, 13 (02) : 179 - 184
  • [5] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [6] CYP2D6 Polymorphism in Suicide Cases - Preliminary Results
    Riccardi, L. N.
    Lanzellotto, R.
    Ceccardi, S.
    Bini, C.
    Fersini, F.
    Govi, A.
    Mazzotti, M. C.
    Ingravallo, F.
    Pelotti, S.
    [J]. IALM 2012: PRESENTATIONS FROM THE 22ND CONGRESS OF THE INTERNATIONAL ACADEMY OF LEGAL MEDICINE, 2013, : 231 - 234
  • [7] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    [J]. MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [8] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [9] Unique case of serotonin toxicity in a poor CYP2D6 metabolizer
    Feininger, E. Sterling
    Dulaney, Anna
    Sanders, Taylor
    Pikus, Angela
    Kopec, Kathryn
    [J]. CLINICAL TOXICOLOGY, 2023, 61 : 71 - 71
  • [10] CYP2D6, Role for Psychological Functioning and Potential Implication for Suicide
    Penas-Lledo, Eva
    Blasco-Fontecilla, Hilario
    Lopez-Castroman, Jorge
    Garcia-Nieto Penas-LLedo, Rebeca
    Baca-Garcia, Enrique
    Llerena, Adrian
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 154S - 154S